Neuralstem IncAdd to My Watchlist

CUR:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 1.49
    Last
  • 0.04  2.76%
    Today's Change
  • 1.45
    Previous Close
  • Today
     
    0.42
    1.96
    52 Week Low - High
8:04 pm ET 5/17/2013
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding69 million
Market Cap$103 million
Return on Equity ttm-220.15%
Last DividendCUR:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.180
EPS: Year Est. 12/13 ttm-0.160
 
EPS: Quarterly Actual 3/13 -0.05
EPS: Quarterly Est. 6/13 -0.04
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate34.62
Company Description
Neuralstem Inc. is a biotherapeutics company utilizing its Human Neural Stem Cell technology to develop cures for diseases of the CNS (central nervous system).
Revenue$407,710
Net Income$-10 million
Total Assets$9 million
Employees17
Web Sitewww.neuralstem.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!